WELLSIM BIOMEDICAL TECHNOLOGIES, INC.
Biotech · Private
A platform for multimodal single-extracellular-vesicle profiling combining next-generation sequencing with multiplex library preparation to simultaneously analyze gene expression and surface proteins
- Grants
- $4.5M
- 12 awards
- Sector median: 1
- Raised
- —
- No Form D on record
- Contracts
- —
- No federal contracts on record
- Patents
- 9
- 7 granted · 2 pending
- Sector median: 2
Capital Timeline
Federal ↑Equity ↓20212022202320242025
| Date | Event | Source | Amount |
|---|---|---|---|
| Federal grant | Department of Health and Human Services · Phase I · A Label-free Extracellular-vesicle Automated Purification System (LEAP System) | $197,500 | |
| Federal grant | Department of Health and Human Services · Phase I · EXODUS-enabled High-throughput Multi-omics Profiling of Extracellular Vesicles for Diagnosis of Preclinical Alzheimer's Disease | $251,359 | |
| Federal grant | Department of Health and Human Services · Phase I · Multi-omics profiling of individual exosomes for their origin-tracing, biomarker discovery, and biological function characterization | $249,974 | |
| Federal grant | Department of Health and Human Services · Phase I · Multi-omics profiling of individual exosomes for their origin-tracing, biomarker discovery, and biological function characterization | $6,500 | |
| Federal grant | Department of Health and Human Services · Phase II · A Label-free Extracellular-vesicle Automated Purification System (LEAP System) | $749,646 | |
| Federal grant | Department of Health and Human Services · Phase I · Link phenotypic characteristics with gene expression profile of single cells at high throughput for drug discovery and cell therapy development | $246,812 | |
| Federal grant | Department of Health and Human Services · Phase I · EXODUS-enabled High-throughput Multi-omics Profiling of Extracellular Vesicles for Diagnosis of Preclinical Alzheimer's Disease | $110,405 | |
| Federal grant | Department of Health and Human Services · Phase I · EXODOTS for diagnostic evaluation and monitoring of Alzheimer's disease | $291,692 | |
| Federal grant | Department of Health and Human Services · Phase II · A Label-free Extracellular-vesicle Automated Purification System (LEAP System) | $749,163 | |
| Federal grant | Department of Health and Human Services · Phase II · Multi-omics profiling of individual exosomes for origin-tracing, biomarker discovery, and biological function characterization | $801,485 | |
| Federal grant | Department of Health and Human Services · Phase II · Multi-omics profiling of individual exosomes for origin-tracing, biomarker discovery, and biological function characterization | $738,347 | |
| Federal grant | Department of Health and Human Services · Phase II · Multi-omics profiling of individual exosomes for origin-tracing, biomarker discovery, and biological function characterization | $122,815 |
Federal grant · SBIR/STTR
Peer position
| # | Company | Contracts | Disclosed equity |
|---|---|---|---|
| 1502 | VIVA VIRAL VACCINES, INC. | — | — |
| 1503 | HELIX BIOMEDIX INC | — | $17M |
| 1504 | VIVOSCRIPT, INC. | — | — |
| 1505 | WELLSIM BIOMEDICAL TECHNOLOGIES, INC. | — | — |
| 1506 | VLP BIOTECH, INC. | — | — |
| 1507 | KINASENSE, LLC | — | — |
| 1508 | BRITEBIO, INC. | — | — |
Ranked on federal contract value rather than capital raised. The equity column is the comparison worth making — companies at the same procurement position often sit at very different points in their funding history.
Patents
- Spatially Barcoded Microarraygranted
- Method For Diagnosis Based On Circulating Extracellular Vesiclesgranted
- Integrated Microfluidic System For Automated Multiplex Analyte Detectiongranted
- Method For Multimodal Profiling Of Individual Extracellular Vesiclesapplication
- Isolation Chip For Isolating Target Particles From Liquid Sample, And Device And Method For Detecting The Target Particlesgranted
- Method And System For Integrating Morphological Characteristics And Gene Expression Of Single-cellapplication
- Spatially Barcoded Microarraygranted
- Isolation Device And Isolation Methodgranted
- Isolation Chip And Manufacturing Method Of The Samegranted
Regulatory activity · Biotech
- New Animal Drugs; Approval of New Animal Drug Applications; Withdrawal of Approval of New Animal Drug Application; Change of SponsorFood and Drug Administration
- Medical Devices; General and Plastic Surgery Devices; Classification of the Skin Patch for Treatment of HyperhidrosisFood and Drug Administration
- Medical Devices; Anesthesiology Devices; Classification of the Monitor for Opioid Induced Impairment of OxygenationFood and Drug Administration
- Medical Devices; Orthopedic Devices; Classification of the Medial Knee Implanted Shock AbsorberFood and Drug Administration
- Medical Devices; Neurological Devices; Classification of the External Lower Extremity Nerve Stimulator for Restless Legs SyndromeFood and Drug Administration
- Medical Devices; General Hospital and Personal Use Devices; Classification of the Infant Supine Sleep SystemFood and Drug Administration
Rules are matched to sector, not to company. Recent activity in a sector is context rather than a signal about this business — until rules are matched to what a company actually builds, the section is shown as context and nothing more.